Jubilant Ingrevia Limited

JUBLINGREA

INE0BY001018

Specialty Chemicals

Market Closed - NSE India S.E. Other stock markets 04:35:03 06/02/2026 pm IST			5-day change	1st Jan Change
613.55 ^INR	-2.00%		-3.42%	-12.78%

06/02	Jubilant Ingrevia Limited, Q3 2026 Earnings Call, Feb 05, 2026
04/02	Jubilant Ingrevia Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI

Jubilant Ingrevia Dec-quarter Consol Net Profit 469 Million Rupees

Published on 02/04/2026 at 07:11 pm IST

Reuters

Latest news about Jubilant Ingrevia Limited

06/02	Jubilant Ingrevia Limited, Q3 2026 Earnings Call, Feb 05, 2026
04/02	Jubilant Ingrevia Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
04/02	Jubilant Ingrevia declares interim dividend of 2.50 rupees per share	RE
04/02	Jubilant Ingrevia Dec-quarter Consol Net Profit 469 Million Rupees	RE
04/02	Diary-India economic, corporate events on February 4	RE
22/12	Anand Rathi Securities Starts Jubilant Ingrevia at Buy with INR975 Price Target	MT
17/12	Kotak Securities Starts Jubilant Ingrevia at Buy with INR870 Price Target	MT
24/11	Jubilant Ingrevia Redeems INR500 Million Commercial Paper at Maturity	MT
28/25/28	Jubilant Ingrevia's Fiscal Q2 Consolidated Profit Rises to INR695 Million	MT
27/25/27	Jubilant Ingrevia Limited, Q2 2026 Earnings Call, Oct 27, 2025
27/25/27	Jubilant Ingrevia Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
27/25/27	Jubilant Ingrevia chairman says expect part-recovery in acetyls portfolio in H2 FY26	RE
27/25/27	Jubilant Ingrevia Sept-quarter consol net profit 694.7 million rupees	RE
15/25/15	Jubilant Ingrevia Redeems INR700 Million Commercial Paper on Maturity	MT
29/25/29	Jubilant Ingrevia Limited Approves Final Dividend for the Financial Year Ended March 31, 2025	CI
29/25/29	Jubilant Ingrevia Limited Appoints Aashti Bhartia as Director	CI
13/25/13	Crisil Affirms A1+ Rating on Jubilant Ingrevia's Commercial Papers	MT
11/25/11	Jubilant Ingrevia issues 500 million rupees commercial papers	RE
01/25/01	Jubilant Ingrevia Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
31/25/31	Jubilant Ingrevia Limited, Q1 2026 Earnings Call, Jul 31, 2025
31/25/31	Jubilant Ingrevia Posts Rise in Fiscal Q1 Consolidated Net Profit	MT
31/25/31	Jubilant Ingrevia Limited Announces Board Changes	CI
23/25/23	Jubilant Ingrevia Raises INR700 Through Issue of Commercial Papers	MT
13/25/13	Nikita Resources, Shyam Sunder Bhartia Family Trust, Jubilant Enpro Sell 9.9 Million Shares In Jubilant Ingrevia Via Bulk Deal Per NSE Data	RE
06/25/06	Jubilant Ingrevia Issues Commercial Papers Of 1 Billion Rupees	RE

Chart Jubilant Ingrevia Limited

Duration

Period

JUBLINGREA: Dynamic Chart

Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.

Employees

2,139

Sector

Specialty Chemicals

Calendar

09/02 - Nuvama India Conference

More about the company